- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 28.10.25 | Lonza to Acquire Redberry SAS | ||
| 28.10.25 | Upperton Installs Fill2Weight Gravimetric Powder Filling Machine at Nottingham Facility | ||
| 28.10.25 | Incyte, Enable Injections Enter enFuse Partnership | ||
| 28.10.25 | Schreiner Taps Jens Vor der Brüggen to Lead Technology & Innovation Management Department | ||
| 27.10.25 | Lilly Agrees to Acquire Adverum Biotechnologies | ||
| 27.10.25 | Novartis Agrees to Acquire Avidity Biosciences | ||
| 23.10.25 | Roche Appoints Head of Group Communications | ||
| 23.10.25 | Serán Bioscience Expands Commercial Manufacturing in Bend, OR | ||
| 23.10.25 | Orion Obtains Exclusive Commercial License for Abzena's Antibody | ||
| 23.10.25 | Syngene Plans to Add Bioconjugation Suite | ||
| 23.10.25 | Secarna Pharmaceuticals, Scenic Biotech Enter Drug Discovery & Co-Development Pact | ||
| 23.10.25 | BioMed X and Daiichi Sankyo Launch Immuno-Oncology Research Team | ||
| 22.10.25 | ProImmune Opens New Global Headquarters in Oxford | ||
| 22.10.25 | Sharp Services Invests $100M in U.S. and European Facilities | ||
| 22.10.25 | Takeda Licenses Late-Stage Cancer Drugs from Innovent in $1.2 Billion Deal | ||
| 22.10.25 | Cambrex Invests $120M to Expand U.S. API Manufacturing Ops | ||
| 22.10.25 | Basking Biosciences Names Dr. Julia Owens as CEO | ||
| 22.10.25 | Charles River, Francis Crick Institute Develop Antibody-Drug Conjugate | ||
| 22.10.25 | Alkermes to Acquire Avadel Pharmaceuticals for $2.1 Billion | ||
| 21.10.25 | Ajinomoto Bio-Pharma, Gene Tools Partner to Broaden Access to PMOs | ||
| 21.10.25 | Adare Expands Pessano Facility in Milan | ||
| 21.10.25 | Newleos Therapeutics Appoints Timothy Noyes as President & CEO | ||
| 21.10.25 | Ventus Therapeutics & Genentech Enter Collaboration | ||
| 21.10.25 | Galapagos Considers Winding Down Cell Therapy Business | ||
| 20.10.25 | Ashland Expands Portfolio of High Purity Sugar Excipients |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .